An MXC blend of 5-Amino-1MQ and L-Carnitine; references address the ingredients separately.
In simple words
Powerhouse Blend combines 5-Amino-1MQ, a small molecule associated with NNMT research, and L-Carnitine, a compound involved in energy metabolism. It is not a peptide blend, and studies of the ingredients do not establish how the combined vial behaves.
Ingredient studies are shown separately. They do not demonstrate the effects, safety or synergy of the combined vial; exact sequences and unlisted proportions are not assumed. The owner-confirmed listing contains 100 mg 5-Amino-1MQ plus 400 mg L-Carnitine total per vial, not per mL.
Cultured adipocytes and diet-induced-obese mice; counts not stated in the reviewed abstract.
A series of NNMT inhibitors was studied for selectivity and cellular metabolism. A potent inhibitor reduced weight and adipose measures in the mouse model.
The abstract discusses a compound series, not verified contents of this vial. No human efficacy or long-term safety follows from these experiments. Full-text verification of the exact catalogue salt/form was unavailable.
PMID 29155147. Indexed abstract checked through Europe PMC on 2026-10-26. Selected evidence, not a systematic review.
37 randomized trials with 2,292 participants; search through January 2019.
Pooled trials found a modest average effect on body weight, but no significant effect on waist circumference or body-fat percentage.
Populations and study quality varied; high-quality studies confirmed only the weight outcome. The abstract is not a comprehensive harms review and does not validate this vial.
PMID 32359762. Indexed abstract checked through Europe PMC on 2026-10-26. Selected evidence, not a systematic review.
Resources
Identity search; no unambiguous compound record assigned to this listing. Check forms and synonyms carefully.
Evidence on studied compounds does not establish the identity, purity, safety, or regulatory approval of the catalogue vial. No Canadian regulatory status is assessed here.
Research questions about Powerhouse Blend
What is Powerhouse Blend?
Powerhouse Blend combines 5-Amino-1MQ, a small molecule associated with NNMT research, and L-Carnitine, a compound involved in energy metabolism. It is not a peptide blend, and studies of the ingredients do not establish how the combined vial behaves.
What types of research are cited for Powerhouse Blend?
The Powerhouse Blend profile contains the following selected evidence on individual ingredients. This is not a systematic review or a complete inventory of research.
Methylquinolinium NNMT inhibitors (2018): Preclinical — cells and mice
Ingredient studies are shown separately. They do not demonstrate the effects, safety or synergy of the combined vial; exact sequences and unlisted proportions are not assumed. The owner-confirmed listing contains 100 mg 5-Amino-1MQ plus 400 mg L-Carnitine total per vial, not per mL.
What do the selected Powerhouse Blend studies not establish?
Methylquinolinium NNMT inhibitors (2018): The abstract discusses a compound series, not verified contents of this vial. No human efficacy or long-term safety follows from these experiments. Full-text verification of the exact catalogue salt/form was unavailable.
L-carnitine and body composition (2020): Populations and study quality varied; high-quality studies confirmed only the weight outcome. The abstract is not a comprehensive harms review and does not validate this vial.
These studies do not establish the identity, purity, safety or effects of the MXC Powerhouse Blend vial. Findings in one formulation, population or experimental model should not be assumed to apply to another.